The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Chalcones and their therapeutic targets for the management of diabetes: Structural and pharmacological perspectives
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Kahn, S. E., Hull, R. L., & Utzschneider, K. M. (2006) · Nature · doi:10.1038/nature05482 · Cited by 5,448
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
The mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
(1971) · Annals of Internal Medicine · doi:10.7326/0003-4819-75-6-991_4 · Cited by 2,379
Diabetic nephropathy: diagnosis, prevention, and treatment
Gross, J. L., de Azevedo, M. J., Silveiro, S. P., Canani, L. H., Caramori, M. L., & Zelmanovitz, T. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.164 · Cited by 1,839
Zander, M., Madsbad, S., Madsen, J. L., & Holst, J. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07952-7 · Cited by 1,297
A review of anti-infective and anti-inflammatory chalcones
Nowakowska, Z. (2007) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2006.09.019 · Cited by 1,084
Dyslipidemia in type 2 diabetes mellitus
Mooradian, A. D. (2009) · Nature Reviews Endocrinology · doi:10.1038/ncpendmet1066 · Cited by 1,042
(1992) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(92)90560-d · Cited by 1,040
Projection of Diabetes Burden Through 2050
Boyle, J. P., Honeycutt, A. A., Narayan, K. M. V., Hoerger, T. J., Geiss, L. S., Chen, H., & Thompson, T. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.11.1936 · Cited by 1,004
International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors
Michalik, L., Auwerx, J., Berger, J. P., Chatterjee, V. K., Glass, C. K., Gonzalez, F. J., Grimaldi, P. A., Kadowaki, T., Lazar, M. A., O’Rahilly, S., et al. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.4.5 · Cited by 1,000
Ehrenkranz, J. R. L., Lewis, N. G., Ronald Kahn, C., & Roth, J. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.532 · Cited by 930
Mechanisms of obesity-associated insulin resistance: many choices on the menu
Qatanani, M., & Lazar, M. A. (2007) · Genes & Development · doi:10.1101/gad.1550907 · Cited by 778
Recent developments in biological activities of chalcones: A mini review
Singh, P., Anand, A., & Kumar, V. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.08.033 · Cited by 710
Dimmock, J. R., Elias, D. W., Beazely, M. A., & Kandepu, N. M. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401182509 · Cited by 599
PTP1B as a drug target: recent developments in PTP1B inhibitor discovery
Zhang, S., & Zhang, Z.-Y. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.03.011 · Cited by 558
Yabe-Nishimura, C. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01347-4 · Cited by 526
Goodman and Gilman's Manual of Pharmacology and Therapeutics
Goodman, L., Gilman, A. G., Brunton, L. L., & Parker, K. L. (2007) · Cited by 396
PTP1B: From the sidelines to the front lines!
Tonks, N. K. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00603-3 · Cited by 371
IJpenberg, A., Jeannin, E., Wahli, W., & Desvergne, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20108 · Cited by 352
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
Richter, B., Bandeira-Echtler, E., Bergerhoff, K., & Lerch, C. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006739.pub2 · Cited by 308
Wahli, W., Braissant, O., & Desvergne, B. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90045-4 · Cited by 291
Targeting the AMPK pathway for the treatment of Type 2 diabetes
Viollet, B. (2009) · Frontiers in Bioscience · doi:10.2741/3460 · Cited by 278
Zhang, W., Hong, D., Zhou, Y., Zhang, Y., Shen, Q., Li, J.-Y., Hu, L.-H., & Li, J. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.05.009 · Cited by 264
Tucci, S. A. (2010) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmsott.s7005 · Cited by 232
Chen, M., Christensen, S. B., Blom, J., Lemmich, E., Nadelmann, L., Fich, K., Theander, T. G., & Kharazmi, A. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.12.2550 · Cited by 221
The Role of Glycogen Synthase Kinase 3β in Insulin-stimulated Glucose Metabolism
Summers, S. A., Kao, A. W., Kohn, A. D., Backus, G. S., Roth, R. A., Pessin, J. E., & Birnbaum, M. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17934 · Cited by 212
Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review
Schemmel, K. E., Padiyara, R. S., & D'Souza, J. J. (2010) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2009.07.005 · Cited by 203
ISRAF, D., KHAIZURIN, T., SYAHIDA, A., LAJIS, N., & KHOZIRAH, S. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.04.025 · Cited by 190
Antidiabetic Activities of Chalcones Isolated from a Japanese Herb, Angelica keiskei
Enoki, T., Ohnogi, H., Nagamine, K., Kudo, Y., Sugiyama, K., Tanabe, M., Kobayashi, E., Sagawa, H., & Kato, I. (2007) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf070720q · Cited by 167
Asati, V., Mahapatra, D. K., & Bharti, S. K. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.10.025 · Cited by 165
Self-citationSynthesis of chalcone derivatives as potential anti-diabetic agents
Hsieh, C.-T., Hsieh, T.-J., El-Shazly, M., Chuang, D.-W., Tsai, Y.-H., Yen, C.-T., Wu, S.-F., Wu, Y.-C., & Chang, F.-R. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.04.108 · Cited by 162
Sulfonamide chalcone as a new class of α-glucosidase inhibitors
Seo, W. D., Kim, J. H., Kang, J. E., Ryu, H. W., Curtis-Long, M. J., Lee, H. S., Yang, M. S., & Park, K. H. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.08.087 · Cited by 159
In vivo anti-diabetic activity of derivatives of isoliquiritigenin and liquiritigenin
Gaur, R., Yadav, K. S., Verma, R. K., Yadav, N. P., & Bhakuni, R. S. (2013) · Phytomedicine · doi:10.1016/j.phymed.2013.10.015 · Cited by 154
Birari, R. B., Gupta, S., Mohan, C. G., & Bhutani, K. K. (2011) · Phytomedicine · doi:10.1016/j.phymed.2011.01.002 · Cited by 150
Nozawa, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.159 · Cited by 143
Polyphenols from Broussonetia papyrifera Displaying Potent α-Glucosidase Inhibition
Ryu, H. W., Lee, B. W., Long, M. J. C., Jung, S., Ryu, Y. B., Lee, W. S., & Park, K. H. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf903068k · Cited by 121
Sato, Y., He, J.-X., Nagai, H., Tani, T., & Akao, T. (2007) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.30.145 · Cited by 117
5-Arylidene-2,4-thiazolidinediones as inhibitors of protein tyrosine phosphatases
Maccari, R., Paoli, P., Ottanà, R., Jacomelli, M., Ciurleo, R., Manao, G., Steindl, T. M., Langer, T., Vigorita, M. G., & Camici, G. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.05.027 · Cited by 114
Mascarello, A., Chiaradia, L. D., Vernal, J. I., Villarino, A., Guido, R. V. C., Perizzolo, P. F., Poirier, V., Wong, D., Martins, P. G. A., Nunes, R. J., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.04.051 · Cited by 111
Chalcones are potent inhibitors of aromatase and 17β-hydroxysteroid dehydrogenase activities
Bail, J.-C. L., Pouget, C., Fagnère, C., Basly, J. P., Chulia, A.-J., & Habrioux, G. (2001) · Life Sciences · doi:10.1016/s0024-3205(00)00974-7 · Cited by 109
Bharatham, K., Bharatham, N., Park, K., & Lee, K. (2008) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2007.11.002 · Cited by 105
Natural PTP1B Inhibitors from broussonetia papyrifera
Chen, R. M., Hu, L. H., An, T. Y., Li, J. X., & Shen, Q. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00757-6 · Cited by 102
Anti-angiogenic and Anti-tumor Activities of 2'-Hydroxy-4'-methoxychalcone
Lee, Y. S., Lim, S. S., Shin, K. H., Kim, Y. S., Ohuchi, K., & Jung, S. H. (2006) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.29.1028 · Cited by 96
Kim, D. W., Long, M. J. C., Yuk, H. J., Wang, Y., Song, Y. H., Jeong, S. H., & Park, K. H. (2013) · Food Chemistry · doi:10.1016/j.foodchem.2013.12.026 · Cited by 96
The role of AMP kinase in diabetes.
Misra, P., & Chakrabarti, R. (2007) · PubMed · Cited by 93
Jung, H. A., Yoon, N. Y., Kang, S. S., et al. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.9.0016 · Cited by 88
Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors
Salum, L. B., Altei, W. F., Chiaradia, L. D., Cordeiro, M. N. S., Canevarolo, R. R., Melo, C. P. D. S., Winter, E., Mattei, B., Daghestani, H. N., Santos‐Silva, M. C., et al. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.02.037 · Cited by 84
Xanthohumol, a Prenylated Chalcone from Beer Hops, Acts as an α-Glucosidase Inhibitor in Vitro
Liu, M., Yin, H., Liu, G., Dong, J., Qian, Z., & Miao, J. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf500426z · Cited by 84
The Chalcone Xanthohumol Inhibits Triglyceride and Apolipoprotein B Secretion in HepG2 Cells
Casaschi, A., Maiyoh, G. K., Rubio, B. K., Li, R., Theriault, A., & Adeli, K. (2004) · Journal of Nutrition · doi:10.1093/jn/134.6.1340 · Cited by 72
Textbook of Receptor Pharmacology
Foreman, J. C., & Johansen, T. (2002) · CRC Press eBooks · doi:10.1201/9781420041071 · Cited by 71
Hollister, L. E., Overall, J. E., & Snow, H. L. (1967) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/20.7.777 · Cited by 68
Yoon, G., Lee, W., Kim, S., & Cheon, S. H. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.054 · Cited by 65
Zhang, T., Yamamoto, N., & Ashida, H. (2014) · Food & Function · doi:10.1039/c3fo60694e · Cited by 64
Sulfonate chalcone as new class voltage-dependent K+ channel blocker
Yarishkin, O. V., Ryu, H. W., Park, J., Yang, M., Hong, S.-G., & Park, K. H. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.10.114 · Cited by 60
Qiu, W., Shen, Q., Yang, F., Wang, B., Zou, H., Li, J.-Y., Li, J. X., & Tang, J. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.017 · Cited by 57
Coumarin chalcone fibrates: A new structural class of lipid lowering agents
Sashidhara, K. V., Palnati, G. R., Sonkar, R., Avula, S. R., Awasthi, C., & Bhatia, G. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.04.026 · Cited by 56
Kawabata, K., Sawada, K., Ikeda, K., Fukuda, I., Kawasaki, K., Yamamoto, N., & Ashida, H. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201000267 · Cited by 52
Peroxisome Proliferator Activated Receptors
Genolet, R., Michalik, L., & Wahli, W. (2005) · Springer eBooks · doi:10.1007/3-540-27194-5_22 · Cited by 49
Sashidhara, K. V., Rao, K. B., Kushwaha, V., Modukuri, R. K., Verma, R., & Murthy, P. K. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.05.029 · Cited by 47
AMPK Activators as Novel Therapeutics for Type 2 Diabetes
Yu, L.-F., Qiu, B., Nan, F., & Li, J. X. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610790980611 · Cited by 42
Jamal, H., Ansari, W. H., & Rizvi, S. J. (2008) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00639.x · Cited by 41
Fang, Q., Zhao, L., Wang, Y., Zhang, Y., Li, Z., Pan, Y., Kanchana, K., Wang, J., Tong, C., Li, D., et al. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.10.021 · Cited by 41
Influence of chalcone analogues on serum glucose levels in hyperglycemic rats
Alberton, E., Damazio, R. G., Cazarolli, L. H., Chiaradia, L. D., Leal, P. C., Nunes, R. J., Yunes, R. A., & Silva, F. R. M. B. (2007) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2007.11.001 · Cited by 39
Dipeptidyl Peptidase-4 as a New Target of Action for Type 2 Diabetes Mellitus: A Systematic Review
Wani, J. H., John‐Kalarickal, J., & Fonseca, V. A. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2008.06.008 · Cited by 37
Beneficial effects of phlorizin on diabetic nephropathy in diabetic db/db mice
Pei, F., Li, B., Zhang, Z., Yu, F., Li, X.-L., Lu, W., Cai, Q., Gao, H., & Shen, L. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.04.010 · Cited by 37
Sun, L., Gao, L., Wei-ping, M., Nan, F., Li, J. X., & Piao, H. (2012) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2012.01431.x · Cited by 28
Bak, E., Park, H.-G., Lee, C.-H., Lee, T.-I., Woo, G., Na, Y., Yoo, Y., & Cha, J. (2011) · BMB Reports · doi:10.5483/bmbrep.2011.44.6.410 · Cited by 25
Some Hormonal Influences on Glucose and Ketone Body Metabolism in Normal Human Subjects
Johnston, D. G., Pernet, A., McCulloch, A., BLESA‐MALPICA, G., Burrin, J. M., & Alberti, K. G. M. M. (1982) · Novartis Foundation symposium · doi:10.1002/9780470720691.ch10 · Cited by 21
Bhalerao, S., Somannavar, M. S., Vernekar, S. S., Ravishankar, R., & Goudar, S. (2014) · Cited by 16
Low and no calorie sweeteners (LNCS); myths and realities.
Serván, P. R., Sierra-Poyatos, R., & Rodríguez, J. S. (2014) · PubMed · doi:10.3305/nh.2014.30.sup2e.8288 · Cited by 10
Adipokines: Soluble Factors from Adipose Tissue Implicated in Cancer
Paz-Filho, G., Mishra, A. K., & Licinio, J. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7660-3_5 · Cited by 4
A New Therapy of Type 2 Diabetes: DPP-4 Inhibitors
Ábel, T. (2011) · InTech eBooks · doi:10.5772/23604 · Cited by 4
Molecular Structure of Receptor Tyrosine Kinases
Gammeltoft, S. (2002) · CRC Press eBooks · doi:10.1201/9781420041071.ch4 · Cited by 2
Cited by
Chalcone: A Privileged Structure in Medicinal Chemistry
Zhuang, C., Zhang, W., Sheng, C., Zhang, W., Xing, C., & Miao, Z. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00020 · Cited by 1,463
Tetrazoles via Multicomponent Reactions
Neochoritis, C. G., Zhao, T., & Dömling, A. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00564 · Cited by 599
Anti-cancer chalcones: Structural and molecular target perspectives
Mahapatra, D. K., Bharti, S. K., & Asati, V. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.05.004 · Cited by 495
Self-citationChalcone synthesis, properties and medicinal applications: a review
Rammohan, A., Reddy, J. S., Sravya, G., Rao, C. N., & Zyryanov, G. V. (2020) · Environmental Chemistry Letters · doi:10.1007/s10311-019-00959-w · Cited by 389
Metadata
- Authors
- Mahapatra, D. K., Asati, V., & Bharti, S. K.
- Venue
- European Journal of Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 92
- Pages
- 839-865
- ISSN
- 0223-5234 (ISSN-L)
- OpenAlex
- W2949784653
- Cited by
- 253
- References
- 75
- FWCI
- 22.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.